Abstract:Abstract Background Bacterial meningitis and meningoencephalitis are associated with devastating neuroinflammation. We and others have demonstrated the importance of glial cells in the initiation of immune responses to pathogens invading the central nervous system (CNS). These cells use a variety of pattern recognition receptors (PRRs) to identify common pathogen motifs and the cytosolic sensor retinoic acid inducible gene-1 (RIG-I) is known to serve as a viral PRR and initiator of interferon (IFN) responses. Intriguingly, recent evidence indicates that RIG-I also has an important role in the detection of bacterial nucleic acids, but such a role has not been investigated in glia. Methods In this study, we have assessed whether primary or immortalized human and murine glia express RIG-I either constitutively or following stimulation with bacteria or their products by immunoblot analysis. We have used capture ELISAs and immunoblot analysis to assess human microglial interferon regulatory factor 3 (IRF3) activation and IFN production elicited by bacterial nucleic acids and novel engineered nucleic acid nanoparticles. Furthermore, we have utilized a pharmacological inhibitor of RIG-I signaling and siRNA-mediated knockdown approaches to assess the relative importance of RIG-I in such responses. Results We demonstrate that RIG-I is constitutively expressed by human and murine microglia and astrocytes, and is elevated following bacterial infection in a pathogen and cell type-specific manner. Additionally, surface and cytosolic PRR ligands are also sufficient to enhance RIG-I expression. Importantly, our data demonstrate that bacterial RNA and DNA both trigger RIG-I-dependent IRF3 phosphorylation and subsequent type I IFN production in human microglia. This ability has been confirmed using our nucleic acid nanoparticles where we demonstrate that both RNA- and DNA-based nanoparticles can stimulate RIG-I-dependent IFN responses in these cells. Conclusions The constitutive and bacteria-induced expression of RIG-I by human glia and its ability to mediate IFN responses to bacterial RNA and DNA and nucleic acid nanoparticles raises the intriguing possibility that RIG-I may be a potential target for therapeutic intervention during bacterial infections of the CNS, and that the use of engineered nucleic acid nanoparticles that engage this sensor might be a method to achieve this goal.

RIG-1 receptor expression in the pathology of Alzheimer’s disease

Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.

RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation?

Expression of Immune Related Genes and Possible Regulatory Mechanisms in Alzheimer's Disease

Immune attack: the role of inflammation in Alzheimer disease

Expression of Immune Related Genes and Possible Regulatory Mechanisms in Alzheimer’s Disease

Identification of immunogenic cell death-related genes involved in Alzheimer's disease

IRE1 signaling exacerbates Alzheimer’s disease pathogenesis

Involvement of formyl peptide receptors in receptor for advanced glycation end products (RAGE) - and amyloid beta 1-42-induced signal transduction in glial cells

Microglia receptors and their implications in the response to amyloid β for Alzheimer’s disease pathogenesis

Neuroinflammation in Alzheimer’s disease: microglial signature and their relevance to disease

Retinoic acid inducible gene-I mediated detection of bacterial nucleic acids in human microglial cells

Key inflammatory pathway activations in the MCI stage of Alzheimer’s disease

Receptor for advanced glycation end products is upregulated in optic neuropathy of Alzheimer’s disease

Identification of Immune Cells and Key Genes associated with Alzheimer's Disease

RIG-LIKE Receptor Signaling Modulates the Innate Immune Response and Astrocyte Activation after Injury to the Spinal Cord (157.6)

Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease

Amyloid-|[beta]| induces NLRP1-dependent neuronal pyroptosis in models of Alzheimer|[rsquo]|s disease

RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease

Systemic Inflammasome Activation and Pyroptosis Associate with the Progression of Amnestic Mild Cognitive Impairment and Alzheimer's Disease.

Ripk1 Mediates A Disease-Associated Microglial Response In Alzheimer'S Disease